Synairgen Limited company information, Employees & Contact Information

Will Synairgen plc (OMY) stock outperform benchmarks - Insider Selling & Free Technical Pattern Based Buy Signals Trung tâm Dự báo KTTV quốc gia

Synairgen to Re-register as Private Company and Delist from AIM TipRanks

Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2024 MarketScreener

Fieldfisher advises on Synairgen's £18 million fundraising Fieldfisher

Synairgen shares stay tradeable post-delisting, as top investor waives restrictions Proactive Investors

Synairgen life science company becomes latest to delist from Aim The Times

Synairgen to go private after shareholder approval By Investing.com Investing.com UK

Aerogen Collaborating on COVID-19 Therapeutics respiratory-therapy.com

SNG001: Synairgen's COVID-19 Antiviral for the Immunocompromised Contagion Live

Synairgen’s Phase III trial in hospitalised Covid-19 fails to meet endpoints Clinical Trials Arena

Antiviral monotherapy for hospitalised patients with COVID-19 is not enough The Lancet

New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution (Published 2020) The New York Times

Synairgen becomes the latest company to eye the AIM exit door Proactive Investors

Synairgen’s inhaled therapy reduces Covid-19 progression risk Clinical Trials Arena

Will Synairgen plc (OMY) stock beat revenue estimates - Weekly Market Outlook & Free Safe Capital Growth Stock Tips Trung tâm Dự báo KTTV quốc gia

Synairgen CEO on funding critical Phase 2 trial for SNG001 Proactive Investors

CanSinoBIO, Synairgen get regulatory approval for Covid-19 trials Clinical Trials Arena

What is the fair value estimate for Synairgen plc (OMY) stock in 2025 - Quarterly Profit Review & Daily Profit Focused Screening Trung tâm Dự báo KTTV quốc gia

Can Synairgen plc (OMY) stock sustain margin levels - 2025 Growth vs Value & Low Drawdown Momentum Trade Ideas Trung tâm Dự báo KTTV quốc gia

Experimental lung drug to be tested on UK coronavirus patients The Guardian

Synairgen hails insightful year and looks forward to more clinical progress in 2023 Proactive financial news

Will Synairgen plc (OMY) stock beat international competition - Weekly Profit Report & Free Expert Approved Momentum Trade Ideas Trung tâm Dự báo KTTV quốc gia

Synairgen share price collapses by 92% as covid-19 trial fails ig.com

Encouraging Results From Trial Of Inhaled Drug To Help COVID-19 Patients University of Southampton

How Synairgen plc (OMY) stock trades after rate cuts - Weekly Risk Report & Consistent Profit Trade Alerts Fundação Cultural do Pará

Global trials set to open for COVID-19 treatment first trialled in Southampton University of Southampton

Synairgen plc: Additional Positive Data in Lung Fibrosis drugdiscoverytrends.com

Fieldfisher advises Synairgen plc on fundraising of up to £87 million to support Phase III trials of its potential COVID-19 treatment Fieldfisher

Synairgen appoints new CFO as incumbent bows out after nearly 20 years Proactive financial news

Coronavirus temporarily closes Splash Cafe in Pismo Beach Cal Coast News

What is Synairgen's drug Interferon Beta-1a and can it treat coronavirus? Metro.co.uk

Will the Synairgen share price ever recover? UK Investor Magazine

Synairgen Plc (SNG.L) Share Price, Updates & RNS News Vox Markets